Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
A US-licensed nurse practitioner or physician reviews your intake and, if BPC-157 is appropriate for you, writes a patient-specific prescription
The full Manatt Health Vital Signs report, A New Federal Era for Medicaid Demonstrations: State Waivers to Watch in 2026 and 2027 , includes state-by-state tracking tables mapping every demonstration in the pipeline.
Volume: 10ml per vial Preservative: 0.9% Benzyl Alcohol Grade: USP Sterility: Sterile, multi-use vial with rubber septum Container: Clear glass vial with flip-off cap Bacteriostatic Water Canada Research Applications Bacteriostatic water is the standard reconstitution solvent for lyophilized research peptides in laboratory settings
a mild stinging sensation may occur due to the quinolinium structure
However, anecdotally, those with Mast Cell or histamine intolerances should be wary and work with a practitioner to prime their immune system with other peptides prior to taking BPC 157
US$ 24.47
US$ 27.09
US$ 28.03
US$ 21.58
